TEDCO, Maryland’s economic engine for technology companies, announced a recent Inclusion Fund investment of $100,000 into Sisu Global Health, a company that is providing hospitals with an autotransfusion device to replace or augment donor blood in emergency situations.
TEDCO, Maryland’s economic engine for technology companies, announced a recent $200,000 investment in Escalate. This recent investment came from TEDCO’s Social Impact Funds.
AGED Diagnostics, based in North Bethesda, Md., is a biotechnology company working to create an early detection and intervention solution for liver disease. Using genomic innovation, the company is working to create a more accurate blood test for liver disease. With this solution, physicians could keep patients in a monitoring program, helping to reduce financial burdens and improve patient outcomes.
AGED Diagnostics, based in North Bethesda, Md., is a biotechnology company working to create an early detection and intervention solution for liver disease. Using genomic innovation, the company is working to create a more accurate blood test for liver disease. With this solution, physicians could keep patients in a monitoring program, helping to reduce financial burdens and improve patient outcomes.
TEDCO, Maryland’s economic engine for technology companies, announced a recent $500,000 Seed Fund investment into Flexnode, Inc., a digital infrastructure company.
TEDCO, Maryland’s economic engine for technology companies, announced a recent $200,000 investment into Natáur. This recent investment came from TEDCO’s Social Impact Funds.
Baltimore-based ARMR Systems’ novel wearable platform stops severe arterial bleeds and can respond to trauma in any theater. While the focus of ARMR’s development initiatives is initially on addressing hemorrhage control needs within the military context, the solution will expand and extend to domestic first-response, law enforcement, common clinical applications, and humanitarian aid in high-risk environments. The company previously received investment from TEDCO’s Seed Fund and the Rural and Underserved Business Recovery from Impact of COVID-19 (RUBRIC) program.
TEDCO, Maryland’s economic engine for technology companies, announced a recent investment $250,000 in Femly Corporation, a minority woman-owned Maryland-based technology company working to increase access to natural and organic hygiene products.
Kalocyte, Inc. is a biotechnology company developing an innovative artificial red blood cell (RBC). Through this innovation, KaloCyte hopes to reduce the leading cause of preventable death after trauma—blood loss.
Maryland-based company working to make surgeon’s lives easier with innovative assistive technology